Your browser doesn't support javascript.
loading
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
Taylor, Peter C; Schiff, Michael H; Wang, Qingmin; Jiang, Yusang; Zhuang, Yanli; Kurrasch, Regina; Daga, Shruti; Rao, Ravi; Tak, Paul P; Hsu, Benjamin.
Afiliación
  • Taylor PC; NDORMS, Botnar Research Centre, University of Oxford, Oxford, UK.
  • Schiff MH; School of Medicine, University of Colorado, Greenwood Village, Colorado, USA.
  • Wang Q; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Jiang Y; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Zhuang Y; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Kurrasch R; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Daga S; GlaxoSmithKline, Uxbridge, UK.
  • Rao R; GlaxoSmithKline, Stevenage, UK.
  • Tak PP; GlaxoSmithKline, Stevenage, UK.
  • Hsu B; Janssen Research & Development, Spring House, Pennsylvania, USA.
Ann Rheum Dis ; 77(5): 658-666, 2018 05.
Article en En | MEDLINE | ID: mdl-29483080

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Productos Biológicos / Antirreumáticos / Adalimumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Rheum Dis Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Productos Biológicos / Antirreumáticos / Adalimumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Rheum Dis Año: 2018 Tipo del documento: Article